- Home
- MLAB vs ALDX Comparison
MLAB vs ALDX Comparison
Compare MLAB & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- MLAB
- ALDX
- Stock Information
- Founded
- MLAB 1982
- ALDX 2004
- Country
- MLAB United States
- ALDX United States
- Employees
- MLAB N/A
- ALDX N/A
- Industry
- MLAB Industrial Machinery/Components
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- MLAB Industrials
- ALDX Health Care
- Exchange
- MLAB Nasdaq
- ALDX Nasdaq
- Market Cap
- MLAB 341.1M
- ALDX 314.6M
- IPO Year
- MLAB N/A
- ALDX 2014
- Fundamental
- Price
- MLAB $79.43
- ALDX $5.40
- Analyst Decision
- MLAB Hold
- ALDX Strong Buy
- Analyst Count
- MLAB 1
- ALDX 2
- Target Price
- MLAB $67.00
- ALDX $9.50
- AVG Volume (30 Days)
- MLAB 97.5K
- ALDX 623.6K
- Earning Date
- MLAB 11-06-2025
- ALDX 11-06-2025
- Dividend Yield
- MLAB 0.81%
- ALDX N/A
- EPS Growth
- MLAB N/A
- ALDX N/A
- EPS
- MLAB N/A
- ALDX N/A
- Revenue
- MLAB $242,351,000.00
- ALDX N/A
- Revenue This Year
- MLAB $5.38
- ALDX N/A
- Revenue Next Year
- MLAB $5.25
- ALDX $63.48
- P/E Ratio
- MLAB N/A
- ALDX N/A
- Revenue Growth
- MLAB 8.33
- ALDX N/A
- 52 Week Low
- MLAB $55.45
- ALDX $1.14
- 52 Week High
- MLAB $155.12
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- MLAB 63.39
- ALDX 51.42
- Support Level
- MLAB $76.85
- ALDX $5.06
- Resistance Level
- MLAB $80.84
- ALDX $5.55
- Average True Range (ATR)
- MLAB 3.17
- ALDX 0.26
- MACD
- MLAB 0.98
- ALDX -0.02
- Stochastic Oscillator
- MLAB 90.16
- ALDX 46.58
About MLAB Mesa Laboratories Inc.
Mesa Laboratories Inc manufactures life sciences tools and critical quality control products. It operates in four divisions: Sterilization and Disinfection Control, which manufactures and sells biological, chemical, and cleaning indicators used to assess the effectiveness of sterilization, decontamination, disinfection, and cleaning processes. Clinical Genomics division develops, manufactures, and sells highly sensitive, low-cost, high-throughput genetic analysis tools and related consumables. The Biopharmaceutical Development division develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. The Calibration Solutions division develops, manufactures, sells, and services quality control products.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.